Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-gu-2022/asco-gu-2022-prostate-cancer/135408-asco-gu-2022-cyclone-2-a-phase-2-3-randomized-placebo-controlled-study-of-abiraterone-acetate-plus-prednisone-with-or-without-abemaciclib-in-patients-with-mcrpc.html
If you do not want to visit that page, you can close this browser tab.
